Medical technology giant Masimo (MASI) saw its shares jump 34.1% in early trading on Tuesday. The surge followed multiple media reports citing sources that the company is nearing an agreement to be acquired by Danaher for $180 per share in cash, totaling $10 billion. Meanwhile, Danaher's stock fell more than 7%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments